Cargando…
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
Hepatocellular carcinoma (HCC) is responsible for roughly 90% of all cases of primary liver cancer, and the cases are on the rise. The treatment of advanced HCC is a serious challenge. Immune checkpoint inhibitor (ICI) therapy has marked a watershed moment in the history of HCC systemic treatment. A...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543580/ https://www.ncbi.nlm.nih.gov/pubmed/36773210 http://dx.doi.org/10.1007/s10238-023-01015-2 |